HBSP (USA)
-
Alibaba se vuelve una empresa pública (B)
Palepu, Krishna G.; Srinivasan, Suraj; Wang, Charles C.Y.; Lane, DavidCase HBS-116S12Accounting and ControlActualización sobre evolución de la acción de Alibaba Group y eventos relacionados en el año siguiente su reunión de septiembre 2014 IPO.Starting at €5.74
-
Identificación de la estructura de capital de una firma (Spanish Version)
Becker, BoCase HBS-212S08FinanceSe les pide a los estudiantes a relacionar los balances ocultas con las descripciones firmes. El caso ayuda a los estudiantes a entender cómo los balances reflejan la industria y características de la empresa.Starting at €8.20
-
Cisco Systems and Offshore Cash
Gow, Ian D.; Wang, Charles C.Y.Case HBS-114027-EAccounting and ControlStarting at €8.20
-
Say on Pay: Qualcomm, Inc. Shareholders Vote 'Maybe', Teaching Note
Srinivasan, Suraj; Wang, Charles C.Y.Teaching Note HBS-114065-EAccounting and ControlThis case centers around Qualcomm shareholders' 2012 Say-on-Pay vote and the dispute between the Institutional Shareholder Services and management regarding the appropriateness of the CEO's compensation plan. Was ISS right that Qualcomm CEO's pay was inflated and justified by benchmarking to aspirational peers? Or was management correct that its CEO's pay is warranted by Qualcomm's recent firm performance?Starting at €0.00
-
Cisco Systems and Offshore Cash, Teaching Note
Gow, Ian D.; Wang, Charles C.Y.Teaching Note HBS-114094-EAccounting and ControlTeaching note for case 114027.Starting at €0.00
-
China Vanke: Battle for Control (A)
Paine, Lynn Sharp; Wang, Charles C.Y.; Lau, Dawn; Woo, Anthony K.Case HBS-318117-EKnowledge and CommunicationStarting at €8.20
-
China Vanke: Battle for Control (D)
Paine, Lynn Sharp; Wang, Charles C.Y.; Lau, Dawn; Woo, Anthony K.Case HBS-318120-EIn the battle for control over China Vanke, the Chinese securities regulator steps in to censure Vanke and Baoneng for acting against the interests of the market and minority shareholders. The Chinese insurance regulator also finds Baoneng to be in violation of insurance regulations, and subjects its insurance arm to severe restrictions on further sales of its products. A rival private property developer, China Evergrande, also joins the fray, bu...Starting at €5.74
-
Roche's Acquisition of Genentech
Baldwin, Carliss Y.; Becker, Bo; Dessain, VincentCase HBS-210040-EFinanceFranz Humer, CEO of the Roche Group, must decide whether to mount a hostile tender offer for the publicly-owned shares of Roche's biotechnology subsidiary, Genentech. The case provides opportunities to analyze Roche's strategy with respect to Genentech, tStarting at €8.20
-
Kroll Bond Rating Agency
Becker, BoCase HBS-212034-EFinanceThe established credit raters were criticized for inflating the mortgage credit bubble that imploded in 2008. A new rating agency, KBRA, is considering how to capitalize on the opportunity this presents and how to enter the industry. A small group of managers have to decide on a business model, how to meet hiring and funding needs, and what types of ratings to start with: municipal, corporate, or structured. Where are the needs for new ratings st...Starting at €8.20
-
L'Occitane en Provence
Becker, Bo; Beyersdorfer, Daniela; Mayfield, E. Scott; Yamazaki, MayukaCase HBS-212051-EFinanceCosmetics company L'Occitane en Provence must decide if it is the right time to go public, and, if so, where to list. The firm could list on Euronext in Paris, close to the firm's headquarters in southern France, on one of the large exchanges in the United States, or perhaps in Asia, where much of the firm's future growth is expected. The case provides opportunities to discuss the benefits and costs of going public, including valuation implicatio...Starting at €8.20